SINGH SHAWN (CHIEF EXECUTIVE OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2021ACC: 0001415889-21-003387
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Aug 2018
+5K
Net shares
Net buyer
$9.7K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$1.95
Trade value
$9.73K
% of position
12.4%
6/30/2021
40.38K→45.38K
Total
Net shares
+5K
Net value
$9.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2021 | A · Award | +5K | $1.95 | $9.73K | 12.4% | 40.38K | 45.38K |
| Total | +5K | $9.73K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned26.23K
Total
26.23K indirect26.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.23K | Indirect |
| Total | 26.23K | 26.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported